STRS OHIO - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
STRS OHIO ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$748
-70.6%
24,900
-64.5%
0.00%
-25.0%
Q1 2023$2,541
+8975.0%
70,200
+8675.0%
0.00%
Q4 2022$28
-99.9%
8000.0%0.00%
Q3 2022$27,000
-99.5%
800
-99.6%
0.00%
-100.0%
Q3 2019$4,946,000
+66.1%
180,000
+100.0%
0.01%
-15.4%
Q2 2019$2,978,000
-5.6%
90,0000.0%0.01%
-7.1%
Q1 2019$3,153,000
+23.3%
90,000
+16.9%
0.01%
+7.7%
Q4 2018$2,557,000
-36.3%
77,000
-3.5%
0.01%
-27.8%
Q3 2018$4,017,000
-17.4%
79,800
-1.8%
0.02%
-14.3%
Q2 2018$4,865,000
-13.3%
81,300
-33.6%
0.02%
-16.0%
Q1 2018$5,610,000
+9.3%
122,500
-4.9%
0.02%
+13.6%
Q4 2017$5,132,000
+8.0%
128,800
+8.4%
0.02%
+10.0%
Q3 2017$4,752,000
-9.5%
118,800
-2.5%
0.02%
-13.0%
Q2 2017$5,249,000
+0.6%
121,800
-26.9%
0.02%0.0%
Q1 2017$5,217,000
-1.4%
166,700
-20.5%
0.02%0.0%
Q4 2016$5,291,000
-2.5%
209,570
-4.6%
0.02%
-4.2%
Q3 2016$5,429,000
+6.8%
219,570
-12.0%
0.02%
+4.3%
Q2 2016$5,083,000
+13.5%
249,570
-15.0%
0.02%
+21.1%
Q1 2016$4,478,000
+17.5%
293,640
+3.5%
0.02%
+11.8%
Q4 2015$3,812,000
+51.5%
283,640
+58.1%
0.02%
+41.7%
Q3 2015$2,516,000
+686.2%
179,400
+849.2%
0.01%
+1100.0%
Q2 2015$320,00018,9000.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 921,962$33,402,6835.00%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 423,500$15,326,4654.28%
ARMISTICE CAPITAL, LLC 4,350,000$157,600,5002.27%
S&T BANK/PA 223,775$8,1071.46%
Aristotle Capital Boston, LLC 1,155,149$41,851,0711.29%
Tributary Capital Management, LLC 353,671$12,813,5001.19%
Bridge City Capital, LLC 62,790$2,274,8821.14%
RICE HALL JAMES & ASSOCIATES, LLC 551,285$19,973,0561.14%
Intrinsic Edge Capital Management LLC 289,704$10,495,9761.05%
Parkman Healthcare Partners LLC 131,878$4,777,9401.04%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders